How Can We Encourage Enhanced Innovation in the Pharma Sector? Punya Salila Srivastava's Insights
Click to start listening
Synopsis
Union Health Secretary Punya Salila Srivastava emphasizes the critical need for innovation in India's pharmaceutical sector at the OPPI summit, calling for enhanced R&D and international collaboration. This comes at a time when India's pharmaceutical exports are on the rise, showcasing the country's potential as a global leader in innovation.
Key Takeaways
- Need for Innovation: Emphasis on shifting from volume to value-based production.
- R&D Focus: Call for intensified research and development within India.
- Export Growth: Pharmaceutical exports expected to surpass $30 billion.
- CRDMOs Role: Highlighting the importance of CRDMOs in the industry.
- Global Capability Centers: Growth of GCCs is crucial for innovation.
New Delhi, Nov 20 (NationPress) Union Health Secretary Punya Salila Srivastava emphasized the urgent need for increased innovation within the pharmaceutical industry during her keynote address at the 60th Annual Summit 2025 of the Organisation of Pharmaceutical Producers of India (OPPI) in the capital.
She underscored the significance of robust collaborations between government ministries and the pharmaceutical sector to improve public health outcomes and tackle global health challenges.
“There is an imperative to promote greater innovation in the pharmaceutical field and shift from a volume-driven approach to one that prioritizes value,” stated the Health Secretary.
She called on OPPI to enhance its emphasis on research and development within India, aiming to establish the nation as a global hub of excellence in pharmaceuticals.
The summit also marked the release of a report detailing the transformative evolution of India's pharmaceutical landscape, transitioning from its historical identity as the 'pharmacy of the world' to becoming a leader in innovation and scientific research.
The report, produced by EY Parthenon and OPPI, highlighted the pharmaceutical sector's crucial role in driving economic growth and improving public health. It revealed that pharmaceutical exports have risen from $15.07 billion in 2013-14 to $27.85 billion in FY 2023-24, with expectations to surpass $30 billion soon.
Moreover, it pointed out the rise of Contract Research and Development Organizations (CRDMOs) and Contract Development and Manufacturing Organizations (CDMOs) as essential components of the pharmaceutical industry.
While the global CRDMO market is anticipated to reach $303 billion by 2028, growing at a CAGR of 9.0%, Indian CRDMOs are making significant investments in advanced manufacturing and analytics, establishing themselves as vital partners in worldwide research and development.
Additionally, the report noted that the establishment and growth of Global Capability Centers (GCCs) by multinational pharmaceutical companies in India is crucial for enhancing the country's innovation ecosystem. Approximately 50% of leading global life sciences companies have established GCCs in India, leveraging local talent and advanced digital capabilities.
Point of View
It is clear that India's pharmaceutical innovation is not just a necessity but a strategic imperative. Emphasizing collaboration between government and industry, as highlighted by Punya Salila Srivastava, could propel India to new heights in global health and economic prosperity. This aligns with the nation's vision for a robust healthcare system.
NationPress
20/11/2025
Frequently Asked Questions
What is the main focus of Punya Salila Srivastava's address?
The main focus is on fostering greater innovation in the pharmaceutical sector and shifting towards a value-based production model.
How much have India's pharmaceutical exports increased recently?
Pharmaceutical exports have surged from $15.07 billion in 2013-14 to $27.85 billion in FY 2023-24, with projections to exceed $30 billion soon.
What role do CRDMOs play in the pharmaceutical industry?
CRDMOs are emerging as pivotal players, investing in advanced manufacturing and analytics to support global research and development.
